We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

Advancing Neurotherapeutics in the 21st Century

Roger N. Rosenberg, MD1,2; Jeffrey L. Saver, MD3,4
[+] Author Affiliations
1University of Texas Southwestern Medical Center at Dallas, Department of Neurology and the Alzheimer's Disease Center, Dallas, Texas
2Editor, JAMA Neurology
3University of California at Los Angeles, Neurology, Los Angeles, California
4Associate Editor, JAMA
JAMA. 2014;311(16):1620-1621. doi:10.1001/jama.2014.4084.
Text Size: A A A
Published online


Neurology is emerging rapidly as a clinical discipline with new and effective therapies for major neurological disorders. This theme issue of JAMA, devoted to neurology, includes 5 original research investigations that provide new data on neurotherapeutic advances and 3 Viewpoints that discuss how therapeutic momentum in neurology must be focused and implemented in the future to ensure progress and effectiveness and to improve health outcomes.

In the first Viewpoint, Birbeck and colleagues1 provide a global perspective of the immense challenge clinical neurology faces in providing basic neurological care to millions of persons worldwide with neurodegenerative, neurovascular, and infectious diseases. The authors project that by 2050, there will be 115 million people with dementia and note that stroke causes more deaths annually than AIDS, tuberculosis, and malaria combined. Their perspective is compelling, highlighting advances in medicine that are now producing a worldwide “epidemiologic transition from infections to chronic diseases.” Addressing health needs will require the conduct of research in low and middle resource countries and global training in neurology.

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles